Herpesviruses often contain cryptic, spliced genes that are not obvious from the initial in silico annotation. Alcelaphine herpesvirus 1 (AlHV-1) contains 72 annotated ORFs but there are also a number of gaps between these that may have protein-coding potential. Comparative analysis of coding potential between AlHV-1 and the related ovine herpesvirus 2 (OvHV-2) revealed a putative novel spliced gene that we have termed A9.5. Analysis of cDNA clones from AlHV-1-infected cells revealed three overlapping clones corresponding to A9.5 and the coding sequence was confirmed by reverse transcription PCR of RNA from AlHV-1-infected cattle tissues. The A9.5 gene was predicted to encode a secreted glycoprotein with molecular mass 19 kDa. Empirical analysis showed that a recombinant haemagglutinin-tagged A9.5 fusion protein was secreted from transfected cells and had a molecular mass of 45 kDa, which was reduced to 20 kDa by endoglycosidase F treatment, confirming that A9.5 was a secreted glycoprotein. In situ RNA hybridization showed that A9.5 was expressed in cells associated with malignant catarrhal fever (MCF) lesions in infected cattle. Detailed analysis of the available OvHV-2 sequences revealed an homologous gene (Ov9.5) with conserved splicing signals and predicted amino acid sequence features in both sequenced isolates of this related virus. We have therefore identified a novel spliced gene in two related macaviruses that is expressed in MCF lesions. Future work will determine its importance for the pathogenesis of disease.
INTRODUCTION
Alcelaphine herpesvirus 1 (AlHV-1) is a ruminant gammaherpesvirus of the genus Macavirus (subfamily Gammaherpesvirinae, family Herpesviridae, order Herpesvirales) that naturally infects wildebeest and causes malignant catarrhal fever (MCF) in susceptible in-contact species such as cattle and deer. The natural infection of wildebeest with AlHV-1 is efficient and subclinical, in contrast to MCF, which is generally sporadic and is almost always fatal in affected animals (reviewed by Russell et al., 2009) . Ovine herpesvirus 2 (OvHV-2) is a related virus that naturally infects sheep worldwide and also causes MCF in susceptible species like cattle, bison and deer. Analysis of PCRamplified DNA sequences and serological determinants from ruminant gammaherpesviruses suggests that there are currently about ten recognized MCF viruses (Li et al., 2005) , of which only AlHV-1 and OvHV-2 have been completely sequenced (Ensser et al., 1997; Hart et al., 2007; Taus et al., 2007) .
The genomes of AlHV-1 and OvHV-2 are collinear with other gammaherpesviruses in their genetic organization and contain about 72 genes each (Ensser et al., 1997; Hart et al., 2007; Taus et al., 2007) , many of which are homologous to genes in other herpesviruses. Bioinformatic analysis of AlHV-1 and OvHV-2 led to the annotation of about ten unique genes that are characteristic of MCF viruses, numbered A1-A10 in AlHV-1 and Ov2-Ov10 in OvHV-2 (reviewed by Russell et al., 2009) . These unique genes are likely to have roles in the unique pathology of MCF and include viral immunomodulators and receptors for host immune molecules (Boudry et al., 2007; Coulter et al., 2001; Jayawardane et al., 2008; Russell et al., 2009) . Of the ten unique genes originally described in AlHV-1, potential functions have been assigned to seven by bioinformatic and functional analysis. The remaining three genes (A1, A4 and A10) have no significant similarity to any known protein and have not been detected as fulllength transcripts and therefore remain putative genes. The potential for discovery of further unique MCF virus genes was demonstrated by the annotation of Ov4.5 in the OvHV-2 genome and the identification of its homologue A4.5 in AlHV-1 (Hart et al., 2007; Mills et al., 2003) . Ov4.5 and A4.5 share similarity to the Bcl-2 gene family (Mills et al., 2003) .
The genomes of both AlHV-1 and OvHV-2 contain several regions within which no genes have currently been annotated, such as a 7.5 kb gap between ORF11 and ORF17, a 7.3 kb gap between ORF69 and ORF73 and a 2.5 kb gap between A9 and A10 (Ensser et al., 1997) . These gene-sparse areas are found adjacent to the terminal repeats and at the boundaries between conserved blocks of genes (Hart et al., 2007) . Bioinformatic analysis of these intergenic regions suggests that they contain no ORFs of significant size and have no obvious sequence similarity to known genes. The recent description of microRNA transcripts in two of these regions in OvHV-2 (Levy et al., 2012) , however, suggests that the full complement of genes and transcripts in these viruses remains to be clearly defined, and that molecular analyses may be required to complement bioinformatic gene assignments. We therefore hypothesized that detailed analysis of intergenic gaps in MCF viruses could identify novel genes.
Here we describe the analysis of one intergenic region at the right-hand end of the unique region of AlHV-1 and the consequent identification, expression and analysis of a novel spliced gene that encodes a secreted glycoprotein. The related virus OvHV-2 encodes an homologous gene, and in both viruses this gene appears to be polymorphic.
RESULTS
Identification of the A9.5 gene and sequence analysis Previous analysis of the genomic sequences of AlHV-1 and OvHV-2 had revealed 72 ORFs (Ensser et al., 1997; Hart et al., 2007; Taus et al., 2007) . We surmised that there might be cryptic, spliced genes in at least some of the gaps between these ORFs. The coding potential in the intergenic regions was initially examined by comparing the sequence of AlHV-1 with the two published genomic sequences of OvHV-2 using the TBLASTX algorithm (Altschul et al., 1990) . This analysis revealed three conserved blocks of coding sequence on the reverse strand between the A9 and A10 ORFs (Fig. 1 ). There were in-frame translation termination codons that meant these did not form part of a continuous ORF. However, analysis of potential splice/ donor acceptor sites using NetGene 2 (http://www.cbs.dtu. dk/services/NetGene2; Brunak et al., 1991; Hebsgaard et al., 1996) suggested the presence of consensus splice donor/ acceptor sequences between these blocks of sequence. From this, we inferred that there could be a novel spliced gene in this region.
To confirm the presence of this gene empirically and to determine the precise coding sequence, we constructed two cDNA libraries using mRNA extracted from AlHV-1-infected bovine turbinate (BT) cells. Assembly of virusspecific cDNA sequences onto the AlHV-1 C500 genome sequence (Ensser et al., 1997) identified three overlapping cDNA clones in the region of the AlHV-1 genome between the A9 and A10 genes (nt 126374-128455), which represented a novel spliced transcript of up to six exons (Fig. 1 ). The three clones had similar polyadenylation sites (nt 126374, 126376 and 126433; Fig. S1 , available in JGV Online) and all contained the same three 39 exons but had different 59 ends. Analysis of the protein-coding potential of the consensus cDNA sequence showed the longest ORF spanned exons 2-6 and encoded 169 aa but had no start codon. Three of these exons corresponded almost exactly to the conserved blocks of sequence found in our TBLASTX analysis of this region (Fig. 1) . Examination of the genomic sequence and the observation of alternative splicing at the start of exons 3 and 4 ( Fig. 1) suggested that a longer version of clone 002-H06 could encode a 170-residue protein in exons 3-6 (Fig. S1 ). This putative proteincoding gene was named A9.5 to reflect its position in the genome. Bioinformatic analysis predicted that the A9.5 protein had an N-terminal signal sequence (D-score 0.759; SignalP 4.0; http://www.cbs.dtu.dk) and ten predicted Nglycosylation sites (NetNGlyc 1.0; http://www.cbs.dtu.dk). The predicted mature polypeptide also contained ten cysteine residues, some of which could be important for the tertiary structure of the protein. The A9.5 polypeptide sequence was checked for functional motifs using InterProScan Sequence Search (http://www.ebi.ac.uk/Tools/ pfa/iprscan) but this analysis only confirmed the detection of an N-terminal signal peptide.
Cloning and expression of the A9.5 coding region
To determine whether the predicted A9.5 coding region was expressed as RNA, reverse transcription PCR (RT-PCR) was performed on RNA from AlHV-1-infected cattle tissues and on RNA from AlHV-1-infected BT cells. Infected tissues and cultured cells both contained A9.5-specific transcripts as defined by amplification of the A9.5ex4-6 RT-PCR product (Table 1) , but the complete coding sequence (CDS) region (A9.5-CDS, Table 1 ) was only amplified from AlHV-1-infected cattle tissue (data not shown). A longer five-exon RT-PCR product [A9.5ex2-6(a), A9.5ex2-6(b); Table 1 ], could not be amplified by either of two primer pairs from any of the RNA sources tested, despite being present in the cDNA library made from AlHV-1-infected BT cells (Fig. 1, clone 01-B01 ). This may indicate low abundance of this transcript or relative inefficiency of the PCR primers. Of note is the fact that all of the PCR products in Table 1 could be amplified from viral genomic DNA prepared from virulent AlHV-1 strain C500 but not from the high-passage attenuated AlHV-1 C500 virus. This is in accord with the published analysis of the attenuated virus genome that suggests that deletions and rearrangements have occurred at the right end of the unique portion of the AlHV-1 genome (Wright et al., 2003) .
The A9.5-CDS RT-PCR product, amplified using RNA from MCF-affected cattle tissue, was inserted into the mammalian expression vector pVR1255 (Norman et al., 1997) , to generate a plasmid that would express a recombinant A9.5 protein, fused at its C terminus to a triple haemagglutinin (HA) tag. This construct, pVR-A9.5-HA, was transfected into HEK293T cells and samples were taken at 24 and 48 h of culture. A9.5-HA protein was purified by affinity chromatography from culture medium and from extracts of the transfected cells. Proteins were resolved by SDS-PAGE and Western blotting. The results revealed that the HA-tagged A9.5 fusion protein from the culture medium migrated with apparent molecular mass of 45 kDa (Fig. 2 , lane a), while a band of~40 kDa was purified from cellular extracts (Fig. 2, 
lane b).
Post-translational modification of A9.5
The presence of multiple N-linked glycosylation sites in the A9.5 polypeptide was supported by the significant retardation of the protein by SDS-PAGE compared with the predicted molecular mass of 24 kDa for the full-length A9.5-HA fusion polypeptide and 21 kDa for mature A9.5-HA without the signal peptide. In order to confirm that A9.5 was glycosylated, affinity-purified A9.5-HA fusion 0 kDa for the untreated A9.5-HA fusion protein (Fig. 2 , lane c). The large change in SDS-PAGE migration caused by PNGase F treatment of A9.5-HA suggests that at least some of the predicted N-linked glycosylation sites in the A9.5 sequence were glycosylated.
Expression of A9.5 in vivo
To identify cells that expressed A9.5 mRNA in tissues from MCF-affected animals, we used RNA in situ hybridization (RNA-ISH) on tissue sections from cattle infected intranasally with pathogenic AlHV-1, as described previously . The A9.5ex4-6 PCR product (Table 1) was used as the source of sense and antisense RNA probes for RNA-ISH of kidney sections from MCFaffected and control cattle. This probe was selected as it contained two introns, making it more likely to detect only spliced A9.5 mRNA and not cross-react with virus genomic DNA. Kidney was used because lymphocyte infiltration in this tissue was only observed in animals with clinical MCF. Initial tests of both A9.5 probes with control, mockinfected cattle tissues showed no staining, while A9.5 mRNA-positive cells could be identified in MCF-affected tissues only with the antisense probe (Fig. 3) . The A9.5-expressing cells were mononuclear inflammatory cells, as denoted by morphology with haematoxylin and eosin (H&E) stained semi-serial sections, and were comparable in frequency and morphology to T-cells infiltrating the kidney of AlHV-1-infected rabbits (Anderson et al., 2007) and cattle (G. C. Russell and H. Todd, unpublished results) . This showed that the A9.5 gene is transcribed in MCF-affected tissue and demonstrated that a significant number of infected cells are present in MCF tissue lesions.
Homologues of A9.5
BLASTX and PSI-BLAST analysis of the A9.5 amino acid sequence revealed segments of similarity within the OvHV-2 genome. No other similar proteins were identified in the GenBank non-redundant protein database using these algorithms. The OvHV-2 homologue had a position analogous to that of A9.5, between the Ov9 and Ov10 genes (Fig. 1) , and was therefore named Ov9.5. Analysis of the putative Ov9.5 gene sequence demonstrated conserved splice donor and acceptor sites that could produce the same exon structure as A9.5 and a continuous ORF within Novel glycoprotein gene in alcelaphine herpesvirus 1 the putative Ov9.5 mRNA with similarities of size and sequence to A9.5. Notably, analysis of the two OvHV-2 genome sequences (Hart et al., 2007; Taus et al., 2007) revealed that the Ov9.5 amino acid sequences were less similar (52 % identity) than the products of all other known ORFs in OvHV-2 (84-100 % identity). To distinguish these Ov9.5 variants, we termed them Ov9.5*01 (Hart et al., 2007) and Ov9.5*02 (Taus et al., 2007) .
Having observed the polymorphism of Ov9.5, we investigated whether A9.5 might be polymorphic by PCR amplification of the A9.5 gene from an AlHV-1-positive DNA sample from an Ankole cow that had died of MCF (Whitaker et al., 2007) . Sequencing of the 839 bp A9.5 gene PCR product (Table 1) showed that this AlHV-1 isolate contained an A9.5 gene with the same coding potential and splice site positions as the C500 strain but the predicted A9.5 protein encoded by this gene was only 80 % identical to the C500 polypeptide. We therefore termed the C500 variant A9.5*01 and the Ankole variant A9.5*02.
Alignment of the A9.5*01 and A9.5*02 predicted polypeptide sequences with those of Ov9.5*01 (Hart et al., 2007) and Ov9.5*02 (Taus et al., 2007) revealed 24 % amino acid identity between the OvHV-2 and AlHV-1 proteins. Despite this low level of identity at the amino acid level, all four proteins were predicted to have N-terminal signal sequences and shared six conserved N-linked glycosylation sites and six conserved cysteine residues (Fig. 4) , suggesting conserved function and lending weight to the assignment of A9.5/Ov9.5 as unique MCF virus genes.
Sequence-structure similarities between the A9.5/Ov9.5 sequences and other proteins of known structure were searched using the profile comparison tool HHpred (Söding, 2005; Söding et al., 2005) by submission of the aligned full-length A9.5/Ov9.5 protein sequences to the HHpred server (http://toolkit.tuebingen.mpg.de/hhpred). Only two proteins among the identified hits were of a similar size to A9.5/Ov9.5. These were the cytokines IL-21 (P50.002) and IL-4 (P50.004), which share a compact four-helix bundle structure stabilized by three disulphide bonds. Structure prediction using QUARK and I-TASSER (Xu & Zhang, 2012; Zhang, 2008) suggests that A9.5 also contains four helices with conserved cysteine residues at or near the ends of each helix (Fig. 4) . This may imply structural similarities between the A9.5 and Ov9.5 proteins and four-helix bundle cytokines, such as IL-4 and IL-21.
DISCUSSION
In this work, we have identified a novel spliced gene (A9.5) in AlHV-1 that appears to be conserved in at least one other MCF virus -OvHV-2. The A9.5 complete coding sequence was found to be transcribed only in tissues of AlHV-1-infected cattle, and this transcript was predicted to encode a secreted glycoprotein that has no clear homologue outside the MCF viruses. Recent microarray analysis of virus transcription in AlHV-1-infected cells has confirmed the detection of a transcript between A9 and A10 that terminated close to the polyadenylation sites for A9.5, although no further analysis was done (Palmeira et al., 2013) .
When expressed as an HA-tagged fusion, the A9.5 glycoprotein was found both in the culture medium and within the cells. These two forms of the A9.5-HA protein had distinct migration in SDS-PAGE. This may reflect incomplete glycosylation or partial processing of the intracellular protein due to overexpression. Treatment of the intracellular form with PNGase F led to a reduction in molecular mass that was in accord with the removal of Nlinked carbohydrate side chains.
Alignment of the predicted primary translation products of A9.5 and Ov9.5 showed that 56 of 150 aligned residues (37 %) were identical and that these conserved residues included six cysteine residues and six predicted N-linked glycosylation sites (Fig. 4) . The conservation of these sequence features between the AlHV-1-and OvHV-2-encoded A9.5 homologues, despite the low overall sequence identity, suggests that the function of this protein in the two viruses is likely to be similar. The detection of weak structure-sequence similarity between the A9.5 homologues and four-helix bundle cytokines may be notable but functional analysis of this novel gene product will be required to confirm or refute the bioinformatic predictions.
RNA-ISH demonstrated that A9.5 was expressed in MCFaffected tissues but it will be of interest to study the expression of this gene further to define its role in infection of the natural reservoir host and in the pathogenesis of MCF. Currently, there is no in situ marker of virus-infected cells in MCF. However, the detection of numerous A9.5-expressing cells in lesions in the kidneys of cattle with MCF suggests that this gene may be a good marker of infection and may have a functional role in MCF pathogenesis. Of note is the fact that reanalysis of proteomic datasets from AlHV-1 virions (Dry et al., 2008) showed no evidence of A9.5 protein in AlHV-1 virus particles propagated in BT cells, in accordance with our inability to amplify the A9.5-CDS from these cells. Thus, A9.5 may only be properly expressed during in vivo infection rather than in culture. It is also of interest to note that this region of the virus genome appears to be affected during the attenuation process (Wright et al., 2003) and that A9.5 could not be amplified from the avirulent 'high passage' variant of AlHV-1. Thus, A9.5 may encode an immunomodulatory molecule whose function is intimately involved in the pathogenesis of MCF. The high degree of polymorphism within this gene in both MCF viruses also suggests the A9.5 and Ov9.5 genes may be under immunological selection. This selection would only operate in the natural hosts where the virus is propagated, so analysis of A9.5/Ov9.5 expression and function in these hosts will be required to address this issue.
The discovery of distinct A9.5 and Ov9.5 sequences in a small number of isolates of MCF viruses demonstrates that this gene is highly polymorphic. The provenance of these isolates may, however, influence their sequences. For example, virus strains found in clinical MCF cases may reflect a specific subset of the virus strains circulating in the reservoir species; virus strains from different regions of the globe may be distinct due to their different evolutionary histories; and maintenance of MCF viruses by in vivo or in vitro passage may affect both sequence and structure. The A9.5 and Ov9.5 genes sequenced so far were from: (i) a laboratory strain of AlHV-1 that had been passaged in vivo in the UK for over 30 years (Plowright et al., 1975) ; (ii) a natural case of AlHV-1 MCF in an Ankole cow in the UK (Whitaker et al., 2007) ; (iii) an in vitro-passaged OvHV-2 cell line derived from an MCF-affected cow in the UK (Hart et al., 2007; Schock et al., 1998) ; and (iv) sheep nasal secretions obtained in the USA (Taus et al., 2007) . Thus, the sequence differences between these A9.5 and Ov9.5 alleles may be influenced by a number of factors. It should also be noted that for OvHV-2 at least, the DNA sequence of the regions immediately flanking the Ov9.5 putative coding region exhibit a far higher degree of sequence similarity (.90 % nucleotide identity) than the coding region (60 % nucleotide identity), suggesting that sequence variation is a specific feature of the A9.5/Ov9.5 coding region. Analysis of a larger number of virus isolates from a range of locations should be performed to determine the true degree of polymorphism and the range of strains in circulation. Analysis of sequence variation in other MCF virus genes has suggested that the AlHV-1 and OvHV-2 genomes are generally much less divergent. For example, the Ov2.5 gene sequenced from seven UK isolates exhibited .99 % nucleotide identity (Jayawardane et al., 2008) , while analysis of sequences obtained from three genomic regions of AlHV-1 from about 45 clinical cases of MCF in South Africa showed a range of translated amino acid identity from about 90 to 97 % GenBank accession numbers EU847312-EU847407).
Several publications have described a range of presentations of sheep-associated MCF, including cases with alimentary or neurological signs in addition to the more common head and eye form (Holliman et al., 2007; Mitchell & Scholes, 2009; Twomey et al., 2002) . It will therefore be of interest to compare Ov9.5 sequences from a range of MCF cases to determine whether distinct strains of OvHV-2 are associated with different clinical presentations of this complex disease.
METHODS
Viruses and infected cattle. AlHV-1 C500 strain was used here exactly as described previously . Briefly, virulent AlHV-1, derived from peripheral blood lymphoid cell suspensions of rabbits infected with AlHV-1 C500 and succumbing to MCF, was propagated in cultures of BT cells. Infected BT cell cultures exhibiting clear cytopathic effects were passaged onto fresh BT cells by a 1 : 4 split no more than four times and were used as a source of infected cells and cell-free virus.
Disease-free and MCF-seronegative male Friesian-Holstein calves of 7 months of age were used to provide AlHV-1-infected tissue for this work. The animal experiments were carried out with the approval of the Moredun Research Institute's Experiments and Ethics Committee and complied fully with the Home Office of Great Britain and Northern Ireland Animals (Scientific Procedures) Act 1986. Following onset of clinical MCF caused by intranasal challenge with~10 5 TCID 50 of pathogenic AlHV-1, animals were euthanized with an overdose of intravenous sodium pentobarbitone. Confirmation of MCF was by histopathology and PCR as described previously . Tissue samples for subsequent expression analysis were cut into 5 mm cubes using sterile disposable scalpels and were stored in RNAlater (Ambion) at 220 uC.
cDNA library construction. Total RNA from control BT cells and from BT cells infected with virulent cell-free AlHV-1 C500 was used for construction of full-length and normalized infected cell cDNA libraries. The cells were harvested 3 days after infection and RNA was extracted using Trizol reagent (Life Technologies) and purified using an RNeasy Mini kit (Qiagen). RNA yield and quality were assayed by spectrophotometry and Agilent Bioanalyser. Only RNA with RNA integrity number .7.5 was used. Three independent high-quality infected cell RNA preparations were pooled to ensure good representation of virus transcripts in the cDNA libraries.
RNA preparations (300 mg) derived from infected and uninfected cells were used for library production (GATC Biotech). Two libraries were constructed in the vector pBluescript II SK(+): (i) a subtracted (normalized) library, enriched for transcripts specific to infected cells, with mean insert size of 450 bp; and (ii) a full-length infected cell library, with mean insert size of 1200 bp. Quality control sequencing of 192 clones randomly selected from the subtracted cDNA library showed 78 different sequences of which 68 were encoded by AlHV-1, and 48 clones sequenced from the full-length library represented 26 sequences of which 11 were from AlHV-1.
DNA sequence analysis. Approximately 500 clones from each library were subjected to sequencing of one DNA strand and the resulting data were analysed using the DNASTAR Lasergene software suite (DNASTAR). The finished clone sequences were aligned with the AlHV-1 genomic DNA sequence using Splign (http://www.ncbi.nlm. nih.gov/sutils/splign/splign.cgi; Kapustin et al., 2008) to define the start and end points of exons. Similarity searches were done using BLAST tools (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi; Altschul et al., 1990 Altschul et al., , 1997 , protein topology was predicted using HMMTOP (http://www.enzim.hu/hmmtop/; Tusnády & Simon, 2001 ) and Nlinked glycosylation sites were predicted using NetNGlyc 1.0 Server (http://www.cbs.dtu.dk/services/NetNGlyc/). Multiple sequence alignments were prepared using the CLUSTAL W algorithm within Lasergene; the MUSCLE program at the University of Wageningen Bioinformatics laboratory (http://www.bioinformatics.nl/tools/muscle.html); and the MAFFT server at the European Bioinformatics Institute (http://www.ebi. ac.uk/Tools/msa/mafft). Structure prediction for the mature A9.5 polypeptide was performed using QUARK and I-TASSER (http://zhanglab. ccmb.med.umich.edu/; Xu & Zhang, 2012; Zhang, 2008) .
Cloning and transfection of A9.5 cDNA into mammalian cells.
RNA from infected cells or tissues was prepared as described above and 5 mg samples from MCF-affected kidney and lymph node were used to make oligo(dT)-primed first-strand cDNA (Superscript III; Life Technologies). Aliquots of cDNA equivalent to 0.5 mg total RNA were used in subsequent PCRs with primers described in Table 1 and KOD hot-start DNA polymerase (Merck Millipore). The 513 bp spliced RT-PCR product encoding the A9.5-CDS was inserted into pCR4-blunt-TOPO (Life Technologies) and sequenced using flanking primers. A verified A9.5 fragment was excised using the restriction enzyme NcoI and was ligated into the mammalian expression vector pVR-MCS-HA, derived from pVR1255 (a kind gift from Vical Inc.; Norman et al., 1997) . To generate pVR-MCS-HA, a synthetic 218 bp double-stranded cassette encoding a ribosome-binding site with start codon, a multiple cloning site, a tobacco etch virus protease cleavage site and an in-frame triple-HA epitope tag (TOP Gene Technologies) was inserted between the NotI and BamHI sites of pVR1255. Analysis confirmed the correct sequence and orientation of one clone (pVR-A9.5-HA) which could express A9.5 polypeptide with a triple-HA Cterminal tag. DNA for transient transfection was prepared from 500 ml lysogeny broth/kanamycin (50 mg ml 21 ) cultures using a Qiagen EndoFree Maxi kit.
HEK293T cells were grown in Iscove's modified Dulbecco's medium (Sigma-Aldrich), containing 5 % FCS and 2 mM L-glutamate, to 70 % confluency before being transfected with plasmid DNA (1 mg per 10 6 cells) using Lipofectamine 2000 (Life Technologies) according to the manufacturer's protocol. The transfection reagent was replaced with fresh medium after 4 h and transfected cells were allowed to grow for up to 72 h before harvesting the cells and medium.
RNA-ISH. The primers A9.5ex4F and A9.5ex6R (Table 1) were used to amplify the 366 bp A9.5ex4-6 fragment from cDNA equivalent to 0.5 mg total RNA from AlHV-1-infected bovine tissue. This PCR product was inserted into the vector pGEM-T-Easy (Promega) and one clone with the predicted sequence was selected for production of RNA probes. Strand-specific DIG-UTP-labelled RNA probes were generated using a DIG RNA labelling kit SP6/T7 (Roche Applied Science). RNA-ISH of DIG-labelled RNA probes was performed on 5 mm sections of 4 % paraformaldehyde-fixed kidney, using an Omnislide thermal cycler and wash module (Hybaid) as described previously (Anderson et al., 2001) . Proteinase K was used at an optimal concentration of 5 mg ml 21 and the A9.5 probes were at 2 ng ml
21
. Hybridized, DIG-labelled sections were visualized using an anti-DIG Fab-alkaline phosphatase antibody conjugate (Roche Applied Science). Sections were counterstained with haematoxylin to improve tissue contrast and aid cell identification. Semi-serial sections were stained with H&E to enable more accurate morphological assessment of any A9.5-positive cells.
